Melt sonocrystallized piroxicam for oral delivery: Particle characterization, solid state analysis, and pharmacokinetics

Expert Opinion on Drug Delivery

Volumn 10, Issue 1, 2013, Pages 17-32

  Gupta, Prem Shankar ^a   Sharma, Vijay ^a   Pathak, Kamla ^a  

^a NH 2   (India)

Author keywords

Melt sonocrystallization; Pharmacokinetics; Piroxicam; Solid state analysis

Indexed keywords

PIROXICAM;

ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; CRYSTALLIZATION; DIFFERENTIAL SCANNING CALORIMETRY; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG DELIVERY DEVICE; DRUG ELIMINATION; DRUG HALF LIFE; DRUG RELEASE; DRUG SOLUBILITY; DRUG STABILITY; FLOW KINETICS; IN VITRO STUDY; IN VIVO STUDY; MAXIMUM PLASMA CONCENTRATION; MELT SONOCRYSTALLIZATION; MELTING POINT; NONHUMAN; PARTICLE SIZE; PHARMACEUTICAL ENGINEERING; PHARMACOLOGICAL PARAMETERS; POWDER; RABBIT; SCANNING ELECTRON MICROSCOPY; SOLID STATE; TABLET FORMULATION; THERMODYNAMICS; TIME TO MAXIMUM PLASMA CONCENTRATION; X RAY POWDER DIFFRACTION;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BIOLOGICAL AVAILABILITY; CALORIMETRY, DIFFERENTIAL SCANNING; CHEMISTRY, PHARMACEUTICAL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CRYSTALLIZATION; MICROSCOPY, ELECTRON, SCANNING; PARTICLE SIZE; PHARMACEUTICAL PREPARATIONS; PIROXICAM; RABBITS; SOLUBILITY; SPECTROPHOTOMETRY, INFRARED; TABLETS; X-RAY DIFFRACTION;

EID: 84871450185     PISSN: 17425247     EISSN: 17447593     Source Type: Journal    
DOI: 10.1517/17425247.2013.736961     Document Type: Article

References (39)

1. Li H, Wang J, Bao Y, et al. Rapid sonocrystallization in the salting-out process. J Cryst Growth 2003;247:192-8 (Pubitemid 35412546)
2. Paradkar A, Maheshwari M, Kamble R, et al. Design and evaluation of celecoxib porous particles using melt sonocrystallization. Pharm Res 2006;23(6):1395-400 (Pubitemid 43946161)
3. Abbas A, Srour M, Tang P, et al. Sonocrystallisation of sodium chloride particles for inhalation. Chem Eng Sci 2007;62:2445-53 (Pubitemid 46498005)
4. Louhi-Kultanen M, Karjalainen M, Rantanen J, et al. Crystallization of glycine with ultrasound. Int J Pharm 2006;320:23-9 (Pubitemid 44128716)
5. Ratsimba B, Biscans B, Delmas H, Jenck J. Sonocrystallization: the end of empiricism? A review on the fundamental investigations and the industrial developments. Kona 1999;17:38-48
6. Thompson LH, Doraiswamy LK. The rate enhancing effect of ultrasound by inducing supersaturation in a solid-liquid system. Chem Eng Sci 2000;55:3085-90 (Pubitemid 30332663)
7. Maheshwari A, Harshal J, Paradkar A. Melt sonocrystallization of ibuprofen: effect on crystal properties. Eur J Pharm Sci 2005;25:41-8 (Pubitemid 40602194)
8. Fried CJ, Lu CM. Analgesics. In: Beale MJ, Block HJ, editors. Wilson and Gisvold's textbook of organic medicinal and pharmaceutical chemistry. 12th edition. Wolters Kluwer (India) Pvt. Ltd; New Delhi: 2010. p. 795-6
9. Tripathi R, Biradar SV, Mishra B, Paradkar AR. Study of polymorphs of progesterone by novel melt sonocrystallization technique: a technical note. AAPS Pharm Sci Tech 2010;11:1493-8
10. Indian Pharmacopoeia. Government of India, Ministry of Health and Family Welfare. Controller of Publication; New Delhi, India, I & II: 1996
11. Mihalic M, Hofman H, Kuftinec J, et al. Piroxicam. In: Florey K, editor. Analytical profiles of drug substances. Reed Elsevier India Private Ltd; New Delhi: 2005. p. 509-32
12. Sinko JP. Martin's Physical pharmacy and pharmaceutical sciences. Lippincott Williams & Wilkins; New Delhi: 2008
13. Aulton ME. The science of dosage form design. Churchill Livingstone, Elsevier; New York: 2008
14. Kumar B, Sharma V, Pathak K. Effect of melt sonocrystallization on pharmacotechnical properties of paracetamol, indomethacin and mefenamic acid characterized by dynamic laser scattering and its impact on solubility. Drug Dev Ind Pharm 2012; Epub ahead of print .. The publication reports the effect of melt sonocrystallization on improved pharmacotechnical properties and solubility.
15. Subramanyam CVS. Textbook of physical pharmaceutics. Vallabh Prakashan; New Delhi: 2009
16. Pathak D, Dahiya S, Pathak K. Solid dispersion of meloxicam: factorially designed dosage form for geriatric population. Acta Pharm 2008;58(1):99-110 (Pubitemid 351415844)
17. Edno L, Bressolle F, Combe B, Galtier M. A reproducible and rapid HPLC assay for quantitation of piroxicam in plasma. J Pharm Biomed Anal 1995;13:785-9
18. Chaudhary PD, Uttekar PS. Meltsonocrystallization: a novel particle engineering technique for solubility enhancement. Int J Pharm Tech Res 2009;1(1):111-20
19. Paradkar AR, Maheshwari M, Ketkar AR, Chauhan B. Preparation and evaluation of ibuprofen beads by meltsolidification technique. Int J Pharm 2003;255:33-42 (Pubitemid 36369588)
20. Dabas S, Shakya P, Sharma V, Pathak K. Effect of milling on correlation between interquartile coefficient of skewness and coefficient of kurtosis in pharmaceutical powders - II. Indian J Pharm Educ Res 2009;43:272-9
21. Chamoli K, Jain D, Pathak K. Effect of milling on correlation between interquartile coefficient of skewness and coefficient of kurtosis in pharmaceutical powders- I. Indian J Pharm Educ Res 2009;40:127-37
22. Fuhrer C. Inter-particulate attraction mechanisms. In: Aldernborn G, Nystro MC, editors. Pharmaceutical powder compaction technology. Marcel Dekker Inc; New York: 1996. 1-15
23. Cain J. An alternative technique for determining ANSI/CEMA standard 550flowability ratings for granular materials. Powder Handling Proc 2002;14(3):218-20 (Pubitemid 35208894)
24. Wouter IMF, Geldart D. Characterizing semi-cohesive powders using angle of repose. Part Part Syst Charact 1996;13:254-9 (Pubitemid 126574046)
25. Carr RL. Evaluating flow properties of solids. Chem Eng 1965;72:163-8
26. Sheth AR, Lubach JW, Munson EJ, et al. Mechanochromism of piroxicam accompanied by intramolecular proton transfer probed by spectroscopic methods and solid phase changes. J Am Chem Soc 2005;127(18):6641-51 (Pubitemid 40667527)
27. Sharma V, Philip AK, Pathak K. Modified polysaccharides as fast disintegrating excipient for orodispersible tablets of roxithromycin. AAPS Pharm Sci Tech 2008;9:87-94
28. El-Kamel AH. Improvement of physicochemical and biopharmaceutical properties of flurbiprofen using melt sonocrystallization technique. Drug Dev Res 2008;69:34-41 (Pubitemid 351804248)
29. Sheth AR, Bates S, Muller FX, Grand DJW. Polymorphism in piroxicam. Cryst Growth Des 2004;4(6):1091-8 (Pubitemid 39531985)
30. Wu K, LI J, Wang W, Winstead DA. Formation and characterization of solid dispersions of piroxicam and poly vinyl pyrollidone using spray drying and precipitation with compressed anti-solvents. J Pharm Sci 2009;98(7):2422-31
31. Shaktshneider TP, Danede F, Capet F, et al. Grinding of drugs with pharmaceutical excipients at cryogenic temperatures. J Therm Anal Calorim 2007;89(3):699-707
32. Tantishaiyakul V, Songkros S, Suknuntha K, et al. Crystal structure transformation and dissolution studies of cimetidine piroxicam coprecipitate and physical mixtures. AAPS Pharm Sci Tech 2009;10(3):789-95
33. Garekani H, Sadeghi F, Badiee A, et al. Crystal habit modifications of ibuprofen and their physico-mechanical characteristics. Drug Dev Ind Pharm 2001;27(8):803-9 (Pubitemid 33029505)
34. Moffat CA, Osselton DM, Widdop B. Clarke's Analysis of drugs and poisons. 3rd edition. Vol. 2 Pharmaceutical Press. London: 2004
35. Dhumal RS, Biradar SV, Paradkar AR, York P. Particle engineering using sonocrystallization: salbutamol sulphate for pulmonary delivery. Int J Pharm 2009;368:129-37
36. George ZP, Dimitrios B, Evagelos K. Effect of physical state and particle size distribution on dissolution enhancement of Nimodipine/PEG solid dispersions prepared by melt mixing and solvent evaporation. AAPS Pharm Sci Tech 2006;8:623-31
37. Yu D, Shen X, Branford-white C, et al. Novel fast disintegrating drug delivery devices with predefined inner structure fabricated by 3-dimensional printing. J Pharm Pharmacol 2008;61:323-9
38. Shargel L. Applied biopharmaceutics and pharmacokinetics. 5th edition. McGraw Hill; London: 2005
39. Dhumal RS, Biradar SV, Yamamura S, et al. Preparation of amorphous cefuroxime axetil nanoparticles by sonoprecipitation for enhancement of bioavailability. Eur J Pharm Biopharm 2008;70:109-15